We've gone from seven to one, and we now have none for outpatient use. The government needs to incentivize pharmaceutical companies to step up.
Data Snapshot: The rise and fall of monoclonal antibodies for Covid-19.
Data Snapshot: The rise and fall of…
Data Snapshot: The rise and fall of monoclonal antibodies for Covid-19.
We've gone from seven to one, and we now have none for outpatient use. The government needs to incentivize pharmaceutical companies to step up.